These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2467091)

  • 1. Double-blind comparison of ketanserin and propranolol in hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Rorive G; Amery A
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):718-25. PubMed ID: 2467091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of ketanserin with propranolol in hypertensive patients: interim report.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; Rorive G; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S140-7. PubMed ID: 2412037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
    Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA
    J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension.
    Ito K; Omae T; Ikeda M; Iimura O; Yoshinaga K; Ishii M; Kaneko Y; Mizuno Y; Masuyama Y; Takeda T
    Drugs; 1988; 36 Suppl 1():18-24. PubMed ID: 3071459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T; Fillastre JP; Mimran A; de Tréglodé D; Schardt F; Rosenthal T; Grossman E; Rocco S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
    Waller PC; Solomon SA; Ramsay LE
    Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrendipine as an antihypertensive agent.
    Zachariah PK
    Eur Heart J; 1987 Nov; 8 Suppl K():63-7. PubMed ID: 3330031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
    Strano A; Novo S; Raineri A; Alaimo G; Abrignani MG; Cutietta A
    J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy with ketanserin: metabolic and hemodynamic effects.
    Levinson PD; Zimlichman R; Goldstein DS; Keiser HR
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):384-9. PubMed ID: 2465437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in the treatment of essential hypertension. A double blind trial against metoprolol followed by one-year open treatment.
    Milei J; Lemus J; Finkielman S; Nahmod VE; Bernardiner E
    Clin Exp Hypertens A; 1989; 11(3):371-89. PubMed ID: 2663239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin and captopril interaction in the treatment of essential hypertensives.
    Lavezzaro G; Ladetto PE; Valente M; Stramignoni D; Zanna C; Assogna G; Salvetti A
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():119-22. PubMed ID: 2285641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
    Maclean D; Mitchell ET; Laing EM; Macdonald FC; Gough KJ; Dow RJ; McDevitt DG
    Br J Clin Pharmacol; 1989 May; 27(5):569-80. PubMed ID: 2667597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.